Mechanisms of allergy and clinical immunologyInduction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance
Section snippets
Tonsil samples
This study has been reviewed and approved by the ethic committee of Cantons of Graubünden and Zurich. Human palatine tonsils were obtained from the hospitals of Davos and Chur, Switzerland. Noninflammed tonsils from patients undergoing tonsillectomy were included in the study. Tonsil samples from atopic donors were compared with those from healthy individuals. Atopic patients showed a polyallergic status according to self-reported allergies to different pollen and foods. All atopic individuals
High numbers of functional CD4+FOXP3+ Treg cells in human palatine tonsils
The cell composition of TMCs showed a major difference in comparison with that of peripheral blood. The percentage of B cells in palatine TMCs was approximately 6 times higher than that of PBMCs, and the percentage of total T cells as well as the CD4+ and CD8+ T-cell compartments was significantly lower in TMCs (Fig 1, A). Although the frequency of T cells in tonsils was lower than in peripheral blood, the percentage of CD3+FOXP3+ and CD4+FOXP3+ Treg cells in TMCs was significantly high (Fig 1,
Discussion
The present study shows that oral tolerance to common allergens through the generation of allergen-specific Treg cells is taking place in human tonsils and suggests a suitable lymphatic organ for direct immune interventions for the treatment of allergic diseases and other immune tolerance–related disorders. Because of their anatomical localization with unique structural and functional features, tonsils mount innate and adaptive immune responses that must discriminate between potentially
References (50)
- et al.
Immunology of the tonsils
Immunol Today
(1998) - et al.
Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery
Immunity
(2008) - et al.
Division of labor, plasticity, and crosstalk between dendritic cell subsets
Curr Opin Immunol
(2008) - et al.
Generation, migration and function of circulating dendritic cells
Curr Opin Immunol
(2006) - et al.
Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells
Blood
(2006) - et al.
Phenotypic characterization of five dendritic cell subsets in human tonsils
Am J Pathol
(2001) - et al.
Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens
J Allergy Clin Immunol
(2005) - et al.
Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors
Blood
(2006) - et al.
Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development
Blood
(2010) Mucosal immune response in the ear, nose and throat
Pediatr Infect Dis J
(2000)
Surgery: are we performing enough tonsillectomies?
Nat Rev Clin Oncol
Immune functions of human nasal mucosa and tonsils in health and disease
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
J Exp Med
In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure
J Exp Med
Therapeutic manipulation of immune tolerance in allergic disease
Nat Rev Drug Discov
The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery
Nat Rev Immunol
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism
J Exp Med
Oral tolerance in the absence of naturally occurring Tregs
J Clin Invest
Regulatory T cells and mechanisms of immune system control
Nat Med
Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
Nat Med
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
J Immunol
Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3
J Exp Med
Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells
J Exp Med
Role of interleukin 10 in specific immunotherapy
J Clin Invest
Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity
Nat Med
Cited by (146)
Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
2024, Annals of Allergy, Asthma and ImmunologyIntroduction to Mechanisms of Allergic Diseases
2022, Allergy EssentialsMemory and naïve gamma delta regulatory T-cell gene expression in the first 24-weeks of peanut oral immunotherapy
2021, Clinical ImmunologyCitation Excerpt :Despite these advancements in food allergy treatments, the POIT mechanisms modulating the adaptive immune system to provide effective desensitization, immune homeostasis, and potentially sustained unresponsiveness have yet to be fully elucidated. CD4 + FOXP3+ T regulatory cells (Tregs) are known to promote the development of oral tolerance to allergens [2] and maintenance of immune homeostasis. Tregs are important in sustaining oral tolerance and preventing allergic disorders, whereas deficiencies in Tregs have been observed to promote allergic disorders [3].
Donor plasmacytoid dendritic cells modulate effector and regulatory T cell responses in mouse spontaneous liver transplant tolerance
2021, American Journal of TransplantationTrained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
2021, Journal of Allergy and Clinical ImmunologyThe Role of Regulatory T Cells in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2024
2024, International Archives of Allergy and Immunology
The authors’ laboratories are supported by Swiss National Foundation grants 32-125249 and 320030-132899 and Christine Kühne-Center for Allergy Research and Education (CK-CARE). O.P. was supported by a postdoctoral fellowship from Ministerio de Educación y Ciencia and FECYT (Spain) and W.W.K by NIH contract HHSN272200700046C.
This work was supported by the European Commission's Seventh Framework Programme under grant agreement no. 261357.
Disclosure of potential conflict of interest: M. Akdis has received research support from the Swiss National Foundation, European Commission FP7 (MeDALL), and Predicta. C. A. Akdis has received research support from Novartis, Stallergenes, the Swiss National Science Foundation, Global Allergy and Asthma European Network, and Christine Kühne-Center for Allergy Research and Education; is a Fellow and interest group member of the American Academy of Allergy, Asthma & Immunology; is Vice President of the European Academy of Allergy and Clinical Immunology; and was a committee member for GA2LEN. The rest of the authors declare that they have no relevant conflicts of interest.